Recent Finacing
Recent Raise
Onkaido Therapeutics is a Moderna-created standalone unit developing mRNA-based oncology therapeutics, advancing a portfolio of preclinical candidates targeting apoptosis, central regulatory nodes, and immunotherapy using Moderna's mRNA platform.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor